J.P. Collet

Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis

J.P. Collet, Yann Allali, Claude Lesty et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2006 · 344 citations

Disaggregation of In Vitro Preformed Platelet-Rich Clots by Abciximab Increases Fibrin Exposure and Promotes Fibrinolysis

J.P. Collet, Gilles Montalescot, Claude Lesty et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2001 · 101 citations · Full text

Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome

Jean‐Sébastien Hulot, Gilles Montalescot, Philippe Lechat et al. · Clinical Pharmacology & Therapeutics · 2005 · 94 citations

Fibrinogen as a risk factor for coronary heart disease.

G Montalescot, J.P. Collet, Rémi Choussat et al. · PubMed · 1998 · 66 citations

Vascular Disease, Thrombosis, Public Health +16

P5367Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials

Paul Guedeney, Sabato Sorrentino, Gennaro Giustino et al. · European Heart Journal · 2019 · 31 citations

Cardiovascular Pharmacology, P5367indirect Comparison, Pharmacotherapy +24